Savara Announces New Employment Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

AUSTIN, Texas–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.
On September 2, 2021, the Compensation Committee…

Click here to view the original article.